Average Co-Inventor Count = 7.62
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (15 from 2,078 patents)
2. Janssen Pharmaceuticals, Inc. (8 from 159 patents)
3. Cellzome Limited (7 from 21 patents)
23 patents:
1. 12404260 - Pyridine rings containing derivatives as MALT1 inhibitors
2. 12077521 - Pyrazole derivatives as MALT1 inhibitors
3. 11267804 - (R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity
4. 11130751 - Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors
5. 10954214 - Pyrazole derivatives as MALT1 inhibitors
6. 10898504 - Substituted nucleoside analogues for use as PRMT5 inhibitors
7. 10894793 - Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors
8. 10888550 - Pyrazole derivatives as MALT1 inhibitors
9. 10526316 - Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitors
10. 10202387 - Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors
11. 10087187 - Imidazopyridazine derivatives as PI3KB inhibitors
12. 10017509 - Macrocylic pyrimidine derivatives
13. 9145399 - Substituted bicyclic triazole derivatives as gamma secretase modulators
14. 9115143 - Substituted indole derivatives as gamma secretase modulators
15. 9079886 - Substituted triazole derivatives as gamma secretase modulators